New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Khiron Life Sciences Corp.
KHRNF
Shape
US Flag

PNK

Unprofitable

Unprofitable

7M

Drug Manufacturers - Specialty & Generic

0.00USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 25, 2024
1W 9900.00 % 1M 0.00 % 3M 9900.00 % 1Y -99.09 %

Key Metrics

Shape
  • Market Cap

    7.01M


  • Shares Outstanding

    70.05B


  • Share in Float

    204.94M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.0001


  • Average Volume


  • Beta

    15.147


  • Range

    1.0E-6-0.02


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://khiron.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.76x

P/S Ratio

0.00x

P/B Ratio

0.1

Debt/Equity

-258.9%

Net Margin

$-0.1

EPS

How KHRNF compares to sector?

P/E Ratio

Relative Strength

Shape

KHRNF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$153M

Shape707%

2025-Revenue

$0.06

Shape389%

2025-EPS

$92M

Shape-707%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.20

arrow
arrow

N/A

-0.06
vs -0.09

Q4.20

arrow
arrow

N/A

-0.02
vs -0.06

Q1.21

arrow
arrow

N/A

-0.04
vs -0.08

Q2.21

arrow
arrow

N/A

-0.03
vs -0.05

Q3.21

arrow
arrow

N/A

-0.02
vs -0.06

Q4.21

arrow
arrow

N/A

-0.11
vs -0.02

Q1.22

arrow
arrow

N/A

-0.03
vs -0.04

Q2.22

arrow
arrow

N/A

-0.01
vs -0.03

Q3.22

arrow
arrow

N/A

-0.02
vs -0.02

Q4.22

arrow
arrow

N/A

-0.01
vs -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

+0%

2.5M  vs 2.5M

Q1.21

arrow
arrow

+49%

2.8M  vs 1.9M

Q2.21

arrow
arrow

+68%

2.8M  vs 1.7M

Q3.21

arrow
arrow

+83%

3.5M  vs 1.9M

Q4.21

arrow
arrow

+44%

3.6M  vs 2.5M

Q1.22

arrow
arrow

+64%

4.6M  vs 2.8M

Q2.22

arrow
arrow

+60%

4.5M  vs 2.8M

Q3.22

arrow
arrow

-4%

3.4M  vs 3.5M

Q4.22

arrow
arrow

+9%

4M  vs 3.6M

Q1.23

arrow
arrow

-12%

4.1M  vs 4.6M

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

-4%

-0.04
vs -0.13

Q1.21

arrow
arrow

-10%

-0.10
vs -0.04

Q2.21

arrow
arrow

-9%

-0.09
vs -0.10

Q3.21

arrow
arrow

-6%

-0.06
vs -0.09

Q4.21

arrow
arrow

-59%

-0.59
vs -0.06

Q1.22

arrow
arrow

-18%

-0.18
vs -0.59

Q2.22

arrow
arrow

-7%

-0.07
vs -0.18

Q3.22

arrow
arrow

-13%

-0.13
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

KHRNF

headlinesoftoday.com

17 hours ago